pristane has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, G; Jain, S; Kundu, GC; Patil, TV | 1 |
| Anderson, AO; Potter, M; Wax, JS | 1 |
2 other study(ies) available for pristane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Down-regulation of osteopontin attenuates breast tumour progression in vivo.
Topics: Animals; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Humans; Mammary Neoplasms, Experimental; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; NF-kappa B; Osteopontin; RNA Interference; RNA, Small Interfering; Terpenes; Transplantation, Heterologous; Urokinase-Type Plasminogen Activator; von Willebrand Factor | 2008 |
Differences in the peritoneal response to pristane in BALB/cAnPt and BALB/cJ mice.
Topics: Animals; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Peritoneum; Plasmacytoma; Polyps; Terpenes | 1985 |